Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Mol Biol Cell ; 17(3): 1375-87, 2006 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-16381816

RESUMO

Receptor-mediated internalization to the endoplasmic reticulum (ER) and subsequent retro-translocation to the cytosol are essential sequential processes required for the productive intoxication of susceptible mammalian cells by Shiga-like toxin-1 (SLTx). Recently, it has been proposed that the observed association of certain ER-directed toxins and viruses with detergent-resistant membranes (DRM) may provide a general mechanism for their retrograde transport to endoplasmic reticulum (ER). Here, we show that DRM recruitment of SLTx bound to its globotriosylceramide (Gb(3)) receptor is mediated by the availability of other glycosphingolipids. Reduction in glucosylceramide (GlcCer) levels led to complete protection against SLTx and a reduced cell surface association of bound toxin with DRM. This reduction still allowed efficient binding and transport of the toxin to the ER. However, toxin sequestration within DRM of the ER was abolished under reduced GlcCer conditions, suggesting that an association of toxin with lipid microdomains or rafts in the ER (where these are defined by detergent insolubility) is essential for a later step leading to or involving retro-translocation of SLTx across the ER membrane. In support of this, we show that a number of ER residents, proteins intimately involved in the process of ER dislocation of misfolded proteins, are present in DRM.


Assuntos
Membrana Celular/efeitos dos fármacos , Membrana Celular/metabolismo , Detergentes/farmacologia , Retículo Endoplasmático/metabolismo , Glucosilceramidas/metabolismo , Toxina Shiga I/metabolismo , Toxina Shiga I/toxicidade , 1-Desoxinojirimicina/análogos & derivados , Animais , Morte Celular/efeitos dos fármacos , Linhagem Celular Tumoral , Chlorocebus aethiops , Retículo Endoplasmático/efeitos dos fármacos , Glicoesfingolipídeos/antagonistas & inibidores , Glicoesfingolipídeos/biossíntese , Células HeLa , Humanos , Membranas Intracelulares/metabolismo , Inibidores de Proteassoma , Transporte Proteico/efeitos dos fármacos , Triexosilceramidas/farmacologia , Células Vero
2.
Biochem Biophys Res Commun ; 355(4): 944-9, 2007 Apr 20.
Artigo em Inglês | MEDLINE | ID: mdl-17336267

RESUMO

The centroblast-specific differentiation marker CD77 (Gb(3)), is the receptor for Shiga-like toxin (SLT). The dynamic relationship between Gb(3)/CD77 and key B-cell membrane proteins was studied in Burkitt's lymphoma cells with a focus on CD20. Engagement of Gb(3)/CD77 with SLT-B reduced the amount of CD20 and CXCR4 available, but levels of BCR, MHC Class II, CD21, CD27 and CD54 remained unchanged. Cholesterol depletion promoted a decrease in the number of sites accessed by CD20, CXCR4 and Gb(3)/CD77 antibodies. Constitutive localisation of Gb(3)/CD77 to lipid rafts was unperturbed by either SLT-B binding or cholesterol depletion, whereas the opposite was true for CD20. The effects were specific to SLT-B, highlighted by the inability of cholera toxin B-subunit to alter CD20 availability. Thus, the binding of Gb(3)/CD77 by its cognate ligand transmits information within the lipid bilayer of model lymphoma cells to impact the behaviour of selective proteins, most notably CD20, via a mechanism influenced by the level of cholesterol within the membrane.


Assuntos
Anticorpos/imunologia , Antígenos CD20/imunologia , Linfoma de Burkitt/imunologia , Linfoma de Burkitt/metabolismo , Modelos Biológicos , Triexosilceramidas/imunologia , Triexosilceramidas/metabolismo , Anticorpos/uso terapêutico , Antígenos CD20/metabolismo , Apoptose/efeitos dos fármacos , Biomarcadores , Linfoma de Burkitt/patologia , Linhagem Celular Tumoral , Toxina da Cólera/farmacologia , Humanos , Bicamadas Lipídicas , Microdomínios da Membrana/efeitos dos fármacos , Microdomínios da Membrana/metabolismo , Proteínas Proto-Oncogênicas c-bcl-2/genética , Proteínas Proto-Oncogênicas c-bcl-2/metabolismo , Toxinas Shiga/farmacologia , Triexosilceramidas/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA